Ann-Marcia Comfort Tukpah, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Care | 1 | 2021 | 2690 | 0.300 |
Why?
|
| Critical Illness | 1 | 2021 | 2705 | 0.300 |
Why?
|
| Patient Discharge | 1 | 2021 | 3428 | 0.290 |
Why?
|
| Patient Readmission | 1 | 2021 | 3241 | 0.270 |
Why?
|
| Pandemics | 1 | 2021 | 8600 | 0.180 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2016 | 3069 | 0.150 |
Why?
|
| Receptors, Aryl Hydrocarbon | 3 | 2016 | 220 | 0.130 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2016 | 173 | 0.130 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 1415 | 0.090 |
Why?
|
| Collagen Type II | 1 | 2010 | 148 | 0.090 |
Why?
|
| Interleukins | 1 | 2014 | 782 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2016 | 896 | 0.080 |
Why?
|
| Arthritis, Experimental | 1 | 2010 | 291 | 0.080 |
Why?
|
| Protein Precursors | 1 | 2010 | 1133 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2010 | 1047 | 0.060 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2010 | 822 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 1 | 2010 | 1036 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 1956 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 3432 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 4350 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2010 | 4110 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2720 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 23816 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2010 | 3298 | 0.040 |
Why?
|
| Thiazoles | 2 | 2016 | 1511 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2010 | 3941 | 0.030 |
Why?
|
| Indoles | 2 | 2016 | 1824 | 0.030 |
Why?
|
| Risk Factors | 1 | 2021 | 73708 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9163 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 79984 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 1824 | 0.020 |
Why?
|
| Emulsions | 1 | 2010 | 152 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1135 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2010 | 384 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 869 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 622 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2010 | 420 | 0.020 |
Why?
|
| Humans | 4 | 2021 | 757566 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2010 | 819 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2010 | 426 | 0.020 |
Why?
|
| Tretinoin | 1 | 2010 | 519 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 2010 | 412 | 0.020 |
Why?
|
| Natural Killer T-Cells | 1 | 2010 | 311 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2010 | 1153 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2016 | 1939 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3257 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 1610 | 0.010 |
Why?
|
| Pancreas | 1 | 2010 | 1676 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2010 | 11469 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5778 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 21990 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2010 | 2295 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2901 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7588 | 0.010 |
Why?
|
| Animals | 4 | 2016 | 167718 | 0.010 |
Why?
|
| Mice | 3 | 2010 | 81066 | 0.010 |
Why?
|
| Peptides | 1 | 2010 | 4338 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 9403 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2010 | 6349 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 18936 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 7502 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10405 | 0.010 |
Why?
|
| Inflammation | 1 | 2010 | 10709 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 12078 | 0.000 |
Why?
|
| Male | 1 | 2010 | 358180 | 0.000 |
Why?
|